{"id":"cefdinir-omnicef","safety":{"commonSideEffects":[{"rate":"15","effect":"Diarrhea"},{"rate":"4","effect":"Vaginal yeast infection"},{"rate":"3","effect":"Nausea"},{"rate":"2","effect":"Headache"},{"rate":"2","effect":"Abdominal pain"},{"rate":"2","effect":"Rash"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Cefdinir works by disrupting the cross-linking of peptidoglycan in the bacterial cell wall, leading to cell wall instability and bacterial death. It has broad-spectrum activity against both gram-positive and gram-negative bacteria, making it effective against a wide range of common infections. The drug is bactericidal, meaning it kills bacteria rather than merely inhibiting their growth.","oneSentence":"Cefdinir is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:40:49.709Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Community-acquired pneumonia"},{"name":"Acute exacerbation of chronic bronchitis"},{"name":"Acute maxillary sinusitis"},{"name":"Pharyngitis/tonsillitis"},{"name":"Uncomplicated skin and skin structure infections"},{"name":"Acute otitis media"}]},"trialDetails":[{"nctId":"NCT06406114","phase":"PHASE2","title":"Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-05-05","conditions":"Drug Allergy, Cephalosporin Allergy, Drug Hypersensitivity","enrollment":300},{"nctId":"NCT04278404","phase":"","title":"Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)","status":"RECRUITING","sponsor":"Duke University","startDate":"2020-03-05","conditions":"Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension, Urinary Tract Infections in Children","enrollment":5000},{"nctId":"NCT00835484","phase":"PHASE1","title":"Cefdinir Capsules 300 mg, Fasting","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2005-07","conditions":"Healthy","enrollment":32},{"nctId":"NCT00835549","phase":"PHASE1","title":"Cefdinir for Oral Suspension 250 mg/5mL, Non-fasting","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2005-03","conditions":"Healthy","enrollment":32},{"nctId":"NCT00834574","phase":"PHASE1","title":"Cefdinir for Oral Suspension 250 mg/5mL, Fasting","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2005-02","conditions":"Healthy","enrollment":32},{"nctId":"NCT00834535","phase":"PHASE1","title":"Cefdinir Capsules 300 mg, Non-fasting","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2005-07","conditions":"Healthy","enrollment":32},{"nctId":"NCT05702762","phase":"PHASE2","title":"Single Dose Aminoglycosides for Acute Uncomplicated Cystitis in the Emergency Department Setting","status":"UNKNOWN","sponsor":"Mercy Health Ohio","startDate":"2022-10-01","conditions":"Urinary Tract Infections","enrollment":160},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT02891915","phase":"PHASE4","title":"Trial to Evaluate Beta-Lactam Antimicrobial Therapy of Community Acquired Pneumonia in Children","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-12-02","conditions":"Pneumonia","enrollment":385},{"nctId":"NCT04664803","phase":"PHASE4","title":"Safety and Efficacy of Cefecin Tab. in Patients With Acute Sinusitis","status":"TERMINATED","sponsor":"Korea United Pharm. Inc.","startDate":"2015-08-31","conditions":"Acute Sinusitis","enrollment":284},{"nctId":"NCT01595529","phase":"PHASE2","title":"The SCOUT Study: \"Short Course Therapy for Urinary Tract Infections in Children\"","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2012-05-18","conditions":"Urinary Tract Infection","enrollment":717},{"nctId":"NCT03756324","phase":"PHASE2, PHASE3","title":"The Effect of Chinese Herbal Medicine for Reducing the Application of Antibiotics in the Treatment of Acute Mastitis","status":"UNKNOWN","sponsor":"Beijing University of Chinese Medicine","startDate":"2018-12-20","conditions":"Mastitis Acute Female","enrollment":306},{"nctId":"NCT02297815","phase":"","title":"Comparative Effectiveness of Antibiotics for Respiratory Infections","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2014-01","conditions":"Acute Otitis Media, Acute Sinusitis, Group A Streptococcal Pharyngitis","enrollment":2472},{"nctId":"NCT03014687","phase":"PHASE4","title":"Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions","status":"RECRUITING","sponsor":"St. Joseph's Hospital and Medical Center, Phoenix","startDate":"2017-07-01","conditions":"Antibiotics, Pituitary Adenoma","enrollment":116},{"nctId":"NCT02447224","phase":"EARLY_PHASE1","title":"Pilot Trial of Antibiotics Versus Surgery for Treating Acute Appendicitis","status":"COMPLETED","sponsor":"Olive View-UCLA Education & Research Institute","startDate":"2015-03","conditions":"Acute Uncomplicated Appendicitis","enrollment":30},{"nctId":"NCT03400735","phase":"PHASE4","title":"Comparison of Cefdinir and Cefdinir/Clavulanic Acid Combination in Adults","status":"UNKNOWN","sponsor":"Neutec Ar-Ge San ve Tic A.Ş","startDate":"2017-11-01","conditions":"Acute Exacerbation of Chronic Bronchitis, Community-Acquired Pneumoniae","enrollment":50},{"nctId":"NCT00147914","phase":"PHASE4","title":"Comparison Study Between Cefdinir & Amoxicilline/Clavulanate in Acute Sinusitis and Assessment of Quality of Life","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2005-02","conditions":"Acute Bacterial Sinusitis","enrollment":100},{"nctId":"NCT00883883","phase":"PHASE1","title":"To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 250 mg/5 ml Oral Suspension Fed Conditions","status":"COMPLETED","sponsor":"Sandoz","startDate":"2005-04","conditions":"Healthy","enrollment":40},{"nctId":"NCT00882154","phase":"PHASE1","title":"To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 300 mg Capsule Fed Conditions","status":"COMPLETED","sponsor":"Sandoz","startDate":"2005-04","conditions":"Healthy","enrollment":28},{"nctId":"NCT00882570","phase":"PHASE1","title":"To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 250mg/5 ml Oral Suspension Fasting Conditions","status":"COMPLETED","sponsor":"Sandoz","startDate":"2005-04","conditions":"Healthy","enrollment":40},{"nctId":"NCT00882700","phase":"PHASE1","title":"To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicef 300 mg Capsule Fasting Conditions","status":"COMPLETED","sponsor":"Sandoz","startDate":"2005-04","conditions":"Healthy","enrollment":28},{"nctId":"NCT01561703","phase":"NA","title":"Comparing Healthcare Utilization Between Adenotonsillectomy Patients With and Without Postoperative Antibiotic Use","status":"COMPLETED","sponsor":"University of Missouri-Columbia","startDate":"2012-03","conditions":"Snoring, Strep Throat","enrollment":58},{"nctId":"NCT01734759","phase":"PHASE1","title":"Influence of Medication Taste on Pediatric Prescribers' Prescribing Habits","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2012-11","conditions":"Healthy","enrollment":50},{"nctId":"NCT01000298","phase":"NA","title":"Effectiveness of Oral Antibiotics in the Treatment of Severe Acute Malnutrition","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2009-12","conditions":"Kwashiorkor, Marasmus","enrollment":2700},{"nctId":"NCT00645125","phase":"PHASE4","title":"A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amoxicillin Antibiotic Suspension Medications","status":"COMPLETED","sponsor":"Abbott","startDate":"2003-01","conditions":"Healthy","enrollment":154},{"nctId":"NCT00645073","phase":"PHASE4","title":"Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis","status":"COMPLETED","sponsor":"Abbott","startDate":"2003-11","conditions":"Acute Bacterial Sinusitis","enrollment":271},{"nctId":"NCT00645203","phase":"PHASE2, PHASE3","title":"Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis Media","status":"COMPLETED","sponsor":"Abbott","startDate":"2002-07","conditions":"Acute Otitis Media","enrollment":447},{"nctId":"NCT00644891","phase":"PHASE4","title":"Pediatric Taste Test Study of Cefdinir (Omnicef) Versus Amoxicillin Antibiotic Suspension Medications","status":"COMPLETED","sponsor":"Abbott","startDate":"2003-01","conditions":"Healthy","enrollment":158},{"nctId":"NCT00644943","phase":"PHASE4","title":"A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amoxicillin/Clavulanate in Pediatric Subjects With Acute Otitis Media","status":"COMPLETED","sponsor":"Abbott","startDate":"2003-02","conditions":"Acute Otitis Media","enrollment":425},{"nctId":"NCT00644774","phase":"PHASE4","title":"A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension Medications","status":"COMPLETED","sponsor":"Abbott","startDate":"2003-01","conditions":"Healthy","enrollment":157},{"nctId":"NCT00645112","phase":"PHASE4","title":"A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithromycin in Pediatric Subjects With Acute Otitis Media","status":"COMPLETED","sponsor":"Abbott","startDate":"2003-11","conditions":"Acute Otitis Media","enrollment":357},{"nctId":"NCT00234949","phase":"PHASE4","title":"A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderate Uncomplicated Skin Infections","status":"COMPLETED","sponsor":"Abbott","startDate":"2005-03","conditions":"Mild to Moderate Uncomplicated Skin and Skin Structure Infections","enrollment":380}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ABORTION MISSED"},{"count":1,"reaction":"COMPUTERISED TOMOGRAM THORAX ABNORMAL"},{"count":1,"reaction":"CYTOMEGALOVIRUS VIRAEMIA"},{"count":1,"reaction":"DEVICE RELATED INFECTION"},{"count":1,"reaction":"KLEBSIELLA BACTERAEMIA"},{"count":1,"reaction":"LOWER RESPIRATORY TRACT INFECTION"},{"count":1,"reaction":"LUNG INFILTRATION"},{"count":1,"reaction":"MATERNAL EXPOSURE DURING PREGNANCY"},{"count":1,"reaction":"PNEUMONIA"},{"count":1,"reaction":"PNEUMONIA BACTERIAL"}],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["ABT-198","Omnicef","cefdinir"],"phase":"marketed","status":"active","brandName":"cefdinir (Omnicef)","genericName":"cefdinir (Omnicef)","companyName":"Abbott","companyId":"abbott","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cefdinir is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins. Used for Community-acquired pneumonia, Acute exacerbation of chronic bronchitis, Acute maxillary sinusitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}